{"id":"https://openalex.org/W21141344","doi":null,"title":"Short- and long-term safety assessment of a two-compound ointment containing calcipotriene/betamethasone dipropionate (Taclonex/Daivobet/Dovobet ointment): hypothalamic-pituitary-adrenal axis function in patients with psoriasis vulgaris.","display_name":"Short- and long-term safety assessment of a two-compound ointment containing calcipotriene/betamethasone dipropionate (Taclonex/Daivobet/Dovobet ointment): hypothalamic-pituitary-adrenal axis function in patients with psoriasis vulgaris.","alternate_titles":[],"publication_year":2010,"publication_date":"2010-08-01","ids":{"openalex":"https://openalex.org/W21141344","mag":"21141344","pmid":"https://pubmed.ncbi.nlm.nih.gov/20684147"},"language":"en","primary_location":{"id":"pmid:20684147","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20684147","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of drugs in dermatology : JDD","raw_type":"Comparative Study"},"parent_works":[],"lineage":["https://openalex.org/W21141344"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5113447676","display_name":"Colin Fleming","orcid":"https://orcid.org/0000-0002-6067-3480","observed_orcids":["https://orcid.org/0000-0002-6067-3480"]},"institutions":[{"id":"https://openalex.org/I2802526638","display_name":"Ninewells Hospital","ror":"https://ror.org/039c6rk82","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2800860831","https://openalex.org/I2802526638"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Colin Fleming","raw_affiliation_strings":["Ninewells Hospital and Medical School, Dundee, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ninewells Hospital and Medical School, Dundee, United Kingdom","institution_ids":["https://openalex.org/I2802526638"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025677565","display_name":"Cecilia Ganslandt","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Cecilia Ganslandt","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5002074294","display_name":"Graham Leese","orcid":"https://orcid.org/0000-0003-0570-5678","observed_orcids":["https://orcid.org/0000-0003-0570-5678"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Graham P Leese","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.9392,"has_fulltext":false,"cited_by_count":22,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.70955472,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":97},"biblio":{"volume":"9","issue":"8","first_page":"969","last_page":"974"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":0.9761000275611877,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":0.9761000275611877,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10837","display_name":"Dermatology and Skin Diseases","score":0.010200000368058681,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12421","display_name":"Adrenal Hormones and Disorders","score":0.004800000227987766,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/calcipotriol","display_name":"calcipotriol","score":0.8690000176429749},{"id":"https://openalex.org/keywords/betamethasone-dipropionate","display_name":"betamethasone dipropionate","score":1.0},{"id":"https://openalex.org/keywords/plaque-psoriasis","display_name":"plaque psoriasis","score":0.8859999775886536},{"id":"https://openalex.org/keywords/hypothalamic-pituitary-adrenal-axis-suppression","display_name":"hypothalamic-pituitary-adrenal axis suppression","score":0.9390000104904175},{"id":"https://openalex.org/keywords/topical-corticosteroids","display_name":"topical corticosteroids","score":0.7950000166893005},{"id":"https://openalex.org/keywords/long-term-safety","display_name":"long-term safety","score":0.7429999709129333}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8813994526863098},{"id":"https://openalex.org/C2779800615","wikidata":"https://www.wikidata.org/wiki/Q4897349","display_name":"Betamethasone dipropionate","level":3,"score":0.8484005928039551},{"id":"https://openalex.org/C2780564577","wikidata":"https://www.wikidata.org/wiki/Q179945","display_name":"Psoriasis","level":2,"score":0.6688870191574097},{"id":"https://openalex.org/C2781162121","wikidata":"https://www.wikidata.org/wiki/Q416132","display_name":"Betamethasone","level":2,"score":0.58905029296875},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.558504045009613},{"id":"https://openalex.org/C2776804153","wikidata":"https://www.wikidata.org/wiki/Q210420","display_name":"Corticosteroid","level":2,"score":0.5367262363433838},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.25660014152526855}],"mesh":[{"descriptor_ui":"D000279","descriptor_name":"Administration, Cutaneous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001623","descriptor_name":"Betamethasone","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D001623","descriptor_name":"Betamethasone","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D001623","descriptor_name":"Betamethasone","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D001623","descriptor_name":"Betamethasone","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D002117","descriptor_name":"Calcitriol","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D002117","descriptor_name":"Calcitriol","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D002117","descriptor_name":"Calcitriol","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D002117","descriptor_name":"Calcitriol","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D003879","descriptor_name":"Dermatologic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D003879","descriptor_name":"Dermatologic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D003879","descriptor_name":"Dermatologic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004338","descriptor_name":"Drug Combinations","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007030","descriptor_name":"Hypothalamo-Hypophyseal System","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009824","descriptor_name":"Ointments","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010913","descriptor_name":"Pituitary-Adrenal System","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D011446","descriptor_name":"Prospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011565","descriptor_name":"Psoriasis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D011565","descriptor_name":"Psoriasis","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":1,"locations":[{"id":"pmid:20684147","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20684147","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of drugs in dermatology : JDD","raw_type":"Comparative Study"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4236547704","https://openalex.org/W197976641","https://openalex.org/W1989200998","https://openalex.org/W2169123097","https://openalex.org/W2095476253","https://openalex.org/W3194880842","https://openalex.org/W3193812210","https://openalex.org/W3214808761","https://openalex.org/W1911056645","https://openalex.org/W2146310816"],"abstract_inverted_index":{"The":[0,45],"two-compound":[1,49,73,100,136,154,157,170],"ointment":[2,50,74,82,101,137,158,171],"(Taclonex/Daivobet/Dovobet":[3],"ointment)":[4],"combining":[5],"calcipotriene":[6,161,180],"50":[7],"microg/g":[8],"and":[9,114],"betamethasone":[10,76],"0.5":[11,77],"mg/g":[12,78],"(as":[13,79],"dipropionate)":[14],"is":[15,25,39],"very":[16],"effective":[17],"in":[18,57,83,117,126],"the":[19,35,48,69,72,92,99,135,139,169],"treatment":[20,148],"of":[21,47,71,91,120,147],"psoriasis":[22,88],"vulgaris.":[23],"There":[24],"a":[26,42,63,118,127],"possibility":[27],"that":[28],"hypothalamo-pituitary-axis":[29],"(HPA)":[30],"suppression":[31],"may":[32],"occur":[33],"if":[34],"potent":[36],"corticosteroid":[37],"component":[38],"absorbed":[40],"to":[41],"sufficient":[43],"extent.":[44],"effect":[46],"on":[51],"HPA":[52,103,109,182],"axis":[53,104,110,183],"function":[54,111],"was":[55,62],"assessed":[56,108],"two":[58],"studies.":[59],"Study":[60,106],"1":[61],"four-week,":[64],"double-blind":[65],"study":[66],"which":[67],"compared":[68],"effects":[70],"with":[75,86,134,151,160,179],"dipropionate;":[80],"Diprosone)":[81],"24":[84],"patients":[85,97,121,167],"extensive":[87],"(involving":[89],"15-30%":[90],"body":[93],"surface":[94],"area).":[95],"No":[96,166],"receiving":[98],"had":[102,181],"suppression.":[105,184],"2":[107],"after":[112],"four":[113,141],"52":[115,174],"weeks":[116,142,146,175],"subset":[119],"(n":[122],"=":[123],"19)":[124],"participating":[125],"long-term":[128],"safety":[129],"study.":[130],"Patients":[131],"were":[132],"treated":[133],"for":[138,172],"first":[140],"followed":[143],"by":[144],"48":[145],"as":[149],"needed":[150],"either":[152],"1)":[153],"ointment;":[155],"2)":[156],"alternating":[159,177],"four-weekly":[162,178],"or":[163,176],"3)":[164],"calcipotriene.":[165],"using":[168],"all":[173]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W21141344","counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":4}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
